Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has begun publishing adverse event data from the FDA Adverse Event Reporting System (FAERS) on a daily basis, marking a …
FDA Begins Daily Publication of Adverse Event Data to Boost Drug Safety Oversight Read More
MALVERN, PA – Endo, Inc. (OTCQX: NDOI) has expanded its voluntary recall of certain Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential mislabeling on product cartons. The affected lots, …
Endo Expands Recall of Clonazepam Tablets Due to Mislabeling Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced that STASKA PHARMACEUTICALS, INC., based in Bennet, NE, has initiated a voluntary recall of one lot of its Ascorbic Acid …
STASKA PHARMACEUTICALS Recalls Ascorbic Acid Solution Due to Glass Contamination Risk Read More
WASHINGTON, D.C. — Gilead Sciences, Inc. (Nasdaq: GILD) has announced a voluntary recall of one lot of its COVID-19 treatment drug, Veklury® (remdesivir) for Injection 100 mg/vial, following the discovery …
Glass Alert in COVID-19 Drug: Gilead’s Swift Recall to Protect Patients Read More
WASHINGTON, D.C. — In a recent announcement by the Food and Drug Administration, Dynarex Corporation has initiated a recall of 62 cases of its Dynacare Baby Powder due to potential …
Urgent Recall: Dynacare Baby Powder Pulled Over Asbestos Concerns Read More
WASHINGTON, D.C. — Bionpharma Inc. this week announced a voluntary recall of a single batch of Atovaquone Oral Suspension, 750mg per mL, due to contamination with Cohnella bacteria. This recall, …
Your Safety First: What You Need to Know About Bionpharma’s Urgent Atovaquone Recall Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced that Smiths Medical issued an Urgent Medical Device Notification on May 29, 2024, addressing potential issues with certain Bivona® …
Alert: Your Safety at Risk with Smiths Medical Tracheostomy Tubes! Act Now Read More